Basic and Diluted Loss per Share (Details) - $ / shares |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 30, 2022 |
Dec. 31, 2021 |
||||
Basic and Diluted Loss per Share [Line Items] | |||||||
Warrants to purchase shares common stock exercise price (in Dollars per share) | $ 0.0001 | ||||||
Options to purchase share | 87,764 | 96,459 | [1] | ||||
Exercise price (in Dollars per share) | $ 3.63 | $ 4.89 | |||||
Restricted stock units shares | 87,764 | 96,459 | 96,459 | 89,049 | |||
Convertible Common Stock [Member] | |||||||
Basic and Diluted Loss per Share [Line Items] | |||||||
Convertible shares outstanding | 2,462,759 | 36,792 | |||||
Restricted Stock Units [Member] | |||||||
Basic and Diluted Loss per Share [Line Items] | |||||||
Restricted stock units shares | 71,280 | 59,200 | |||||
Average grant date fair value per share (in Dollars per share) | $ 10.35 | $ 16.2 | |||||
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|